Comparison of early- and new-generation drug-eluting stent implantations for ostial right coronary artery lesions.

about

Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture.

P2860

Q47928581-8730CCA8-DC41-4546-88F5-1C4C0B255583

P2860

Comparison of early- and new-generation drug-eluting stent implantations for ostial right coronary artery lesions.

Item

http://www.wikidata.org/entity/Q40400848

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparison of early- and new-g ...... right coronary artery lesions.

@en

type

Item

label

Comparison of early- and new-g ...... right coronary artery lesions.

@en

prefLabel

Comparison of early- and new-g ...... right coronary artery lesions.

@en

P1476

Comparison of early- and new-g ...... right coronary artery lesions.

@en

P2093

Kensuke Takagi

http://www.w3.org/2001/XMLSchema#string

Sunao Nakamura

http://www.w3.org/2001/XMLSchema#string

Toru Naganuma

http://www.w3.org/2001/XMLSchema#string

Yusuke Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical end points in coronary stent trials: a case for standardized definitions.

Would SYNTAX have been a positive trial if XIENCE V had been used instead of TAXUS?: A meta-analysis of a first-generation vs. a second-generation drug-eluting stent system.

Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial.

The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions.

Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease.

Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study.

Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis.

Clinical and angiographic outcome after sirolimus-eluting stent implantation in aorto-ostial lesions.

Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.

2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ s

P31

scholarly article

P356

10.1111/1755-5922.12247

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28039928

http://www.w3.org/2001/XMLSchema#string

Comparison of early- and new-generation drug-eluting stent implantations for ostial right coronary artery lesions.

about

P2860

P2860

Comparison of early- and new-generation drug-eluting stent implantations for ostial right coronary artery lesions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P577

P698